section name header

References

Psoriasis - Related Resources

Cochrane reviews

Other evidence summaries

Literature

  • van Geel MJ, Mul K, de Jager ME et al. Systemic treatments in paediatric psoriasis: a systematic evidence-based update. J Eur Acad Dermatol Venereol 2015;29(3):425-37. [PubMed]
  • Mason A, Mason J, Cork M et al. Topical treatments for chronic plaque psoriasis: an abridged Cochrane systematic review. J Am Acad Dermatol 2013;69(5):799-807. [PubMed]
  • Boehncke WH, Boehncke S, Schön MP. Managing comorbid disease in patients with psoriasis. BMJ 2010 Jan 15;340():b5666. [PubMed]
  • Menter A, Griffiths CE. Current and future management of psoriasis. Lancet 2007 Jul 21;370(9583):272-84. [PubMed]
  • Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985 Sep;13(3):450-6. [PubMed]
  • Jacobson C, Cornell RC, Savin RC. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis. Cutis 1986 Mar;37(3):213-4, 216, 218-20. [PubMed]
  • Olsen EA, Cram DL, Ellis CN, Hickman JG, Jacobson C, Jenkins EE, Lasser AE, Lebwohl M, Leibsohn E, Medansky RS. A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis. J Am Acad Dermatol 1991 Mar;24(3):443-7. [PubMed]
  • Tham SN, Lun KC, Cheong WK. A comparative study of calcipotriol ointment and tar in chronic plaque psoriasis. Br J Dermatol 1994 Nov;131(5):673-7. [PubMed]
  • Runne U, Kunze J. Short-duration ('minutes') therapy with dithranol for psoriasis: a new out-patient regimen. Br J Dermatol 1982 Feb;106(2):135-9. [PubMed]
  • Kragballe K, Beck HI, Søgaard H. Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study. Br J Dermatol 1988 Aug;119(2):223-30. [PubMed]
  • Kragballe K. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903) Arch Dermatol 1989 Dec;125(12):1647-52. [PubMed]
  • Dubertret L, Wallach D, Souteyrand P, Perussel M, Kalis B, Meynadier J, Chevrant-Breton J, Beylot C, Bazex JA, Jurgensen HJ. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study. J Am Acad Dermatol 1992 Dec;27(6 Pt 1):983-8. [PubMed]
  • Highton A, Quell J. Calcipotriene ointment 0.005% for psoriasis: a safety and efficacy study. Calcipotriene Study Group. J Am Acad Dermatol 1995 Jan;32(1):67-72. [PubMed]
  • Lebwohl M, Siskin SB, Epinette W, Breneman D, Funicella T, Kalb R, Moore J. A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J Am Acad Dermatol 1996 Aug;35(2 Pt 1):268-9. [PubMed]
  • Lebwohl MG, Breneman DL, Goffe BS, Grossman JR, Ling MR, Milbauer J, Pincus SH, Sibbald RG, Swinyer LJ, Weinstein GD, Lew-Kaya DA, Lue JC, Gibson JR, Sefton J. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis. J Am Acad Dermatol 1998 Oct;39(4 Pt 1):590-6. [PubMed]
  • Gollnick H, Menter A. Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis. Br J Dermatol 1999 Apr;140 Suppl 54():18-23. [PubMed]
  • Kragballe K, Gjertsen BT, De Hoop D, Karlsmark T, van de Kerkhof PC, Larkö O, Nieboer C, Roed-Petersen J, Strand A, Tikjøb G. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991 Jan 26;337(8735):193-6. [PubMed]
  • Cunliffe WJ, Berth-Jones J, Claudy A, Fairiss G, Goldin D, Gratton D, Henderson CA, Holden CA, Maddin WS, Ortonne JP. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol 1992 May;26(5 Pt 1):736-43. [PubMed]
  • Molin L, Cutler TP, Helander I, Nyfors B, Downes N. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group. Br J Dermatol 1997 Jan;136(1):89-93. [PubMed]
  • Bruce S, Epinette WW, Funicella T, Ison A, Jones EL, Loss R Jr, McPhee ME, Whitmore C. Comparative study of calcipotriene (MC 903) ointment and fluocinonide ointment in the treatment of psoriasis. J Am Acad Dermatol 1994 Nov;31(5 Pt 1):755-9. [PubMed]
  • Meffert H, Metz D, Sönnichsen N. [Selected ultraviolet phototherapy (SUP) of psoriasis vulgaris using fluorescent bulbs. I. Results of a therapeutical trial (author's transl)] Dermatol Monatsschr 1981 Apr;167(4):210-6. [PubMed]
  • Pinzer B, Kadner H, Kleine-Natrop HE. [Selective ultraviolet-phototherapy (SUP) in psoriasis, especially in exanthematic eruptions (author's transl)] Dermatol Monatsschr 1981 May;167(5):293-7. [PubMed]
  • Lowe NJ, Prystowsky JH, Bourget T, Edelstein J, Nychay S, Armstrong R. Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone. J Am Acad Dermatol 1991 Apr;24(4):591-4. [PubMed]
  • Green C, Lakshmipathi T, Johnson BE, Ferguson J. A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy vs. etretinate (re-TL-01) vs. etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients. Br J Dermatol 1992 Jul;127(1):5-9. [PubMed]
  • Hannuksela M, Karvonen J. Trioxsalen bath plus UVA effective and safe in the treatment of psoriasis. Br J Dermatol 1978;99:703-707
  • Salo OP, Lassus A, Taskinen J. Trioxsalen bath plus UVA treatment of psoriasis. Plasma concentration of the drug and clinical results. Acta Derm Venereol 1981;61(6):551-4. [PubMed]
  • Saurat JH, Geiger JM, Amblard P, Beani JC, Boulanger A, Claudy A, Frenk E, Guilhou JJ, Grosshans E, Mérot Y. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis. Dermatologica 1988;177(4):218-24. [PubMed]
  • Griffiths CE, Clark CM, Chalmers RJ, Li Wan Po A, Williams HC. A systematic review of treatments for severe psoriasis. Health Technol Assess 2000;4(40):1-125. [PubMed]
  • Mason J, Mason AR, Cork MJ. Topical preparations for the treatment of psoriasis: a systematic review. Br J Dermatol 2002 Mar;146(3):351-64. [PubMed]
  • Weinstein GD, Krueger GG, Lowe NJ, et al. Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. J Am Acad Dermatol 1997 Jul;37(1):85-92. [PubMed]
  • Asumalahti K, Ameen M, Suomela S, et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol 2003 Apr;120(4):627-32. [PubMed]
  • Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy--an effective treatment for psoriasis. Br J Dermatol 1988 Dec;119(6):691-6. [PubMed]
  • Karvonen J, Kokkonen EL, Ruotsalainen E. 311 nm UVB lamps in the treatment of psoriasis with the Ingram regimen. Acta Derm Venereol 1989;69(1):82-5. [PubMed]
  • Gordon PM, Diffey BL, Matthews JN, Farr PM. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol 1999 Nov;41(5 Pt 1):728-32. [PubMed]
  • Markham T, Rogers S, Collins P. Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis. Arch Dermatol 2003 Mar;139(3):325-8. [PubMed]
  • Stern RS. Psoralen and ultraviolet a light therapy for psoriasis. N Engl J Med 2007 Aug 16;357(7):682-90. [PubMed]

Primary/Secondary Keywords